Physician

Haris Inam Mirza, MD

According to 2025 Medicare claims, Haris Mirza, MD (NPI: 1912956335) practices infectious disease in the Ocala, FL market, with the plurality of this provider's patient population coming from Marion, FL. This provider's primary affiliated billing organization is OCALA INFECTIOUS DISEASE AND WOUND CENTER, INC (NPI: 1093911935; TIN: 201422124) and primary practice location at 34471-7848. Mirza is affiliated with the Primary Care Alliance, LLC (ACO ID: D0010), participating under the REACH model.

Mirza's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 649 traditional Medicare patients, billed 357,621 HCPCS/CPT codes, and received $1,339,398 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 2,330 prescription claims across 295 beneficiaries totaling $853,866 in drug costs, led by Triumeq (Abacavir/Dolutegravir/Lamivudi). DME data shows 17 claims. Open Payments data shows 69 records totaling $1,870. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $9,551 and ending at $11,484.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	956	256,176	$1,254,892
2016	1,129	353,358	$1,329,217
2017	1,121	411,341	$1,378,984
2018	895	440,358	$1,301,054
2019	956	581,513	$1,375,047
2020	796	407,033	$1,110,699
2021	742	369,765	$1,323,642
2022	665	423,486	$1,223,855
2023	660	392,089	$1,272,603
2024	649	357,621	$1,339,398

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	415	2,351	$1,140,369
2016	433	2,174	$981,939
2017	397	2,098	$615,780
2018	310	2,007	$771,734
2019	280	1,562	$660,441
2020	362	1,782	$845,104
2021	333	1,736	$729,153
2022	362	1,972	$1,006,513
2023	353	2,461	$1,022,294
2024	295	2,330	$853,866

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	24	$921
2016	25	58	$1,018
2017	38	60	$9,943
2018	36	37	$2,803
2019	93	135	$6,886
2020	283	452	$27,547
2021	123	215	$13,341
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	17	$772

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	162	323	$133
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	146	146	$122
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	436	2,774	$94
97597	Removal of tissue from wound, 20.0 sq cm or less	175	1,412	$74
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	245	738	$66

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Triumeq	Abacavir/Dolutegravir/Lamivudi	35	1,050	$140,384
Gammagard Liquid	Immun Glob G(Igg)/Gly/Iga Ov50	36	756	$128,180
Octagam	Immun Globg(Igg)/Malt/Iga Ov50	12	336	$72,154
Juluca	Dolutegravir/Rilpivirine	19	570	$70,553
Vancomycin Hcl	Vancomycin Hcl	148	1,290	$36,942

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A6446	Conforming bandage, non-elastic, knitted/woven, sterile, width greater than or equal to three inches and less than five inches, per yard	N	N/R	17	$772

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	69	$1,870	Gilead Sciences, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Haris Inam Mirza, MD?

Tedicare shows public-source Medicare data for Haris Inam Mirza, MD (NPI 1912956335), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Haris Inam Mirza, MD have ACO affiliation data?

Haris Inam Mirza, MD is shown with ACO affiliation data for Primary Care Alliance, LLC (REACH, ACO ID D0010).

What billing organization is linked to Haris Inam Mirza, MD?

Haris Inam Mirza, MD is linked to OCALA INFECTIOUS DISEASE AND WOUND CENTER, INC (billing NPI 1093911935) in the available physician profile data.

Does Haris Inam Mirza, MD have Open Payments data?

Haris Inam Mirza, MD has 69 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.